Yangjin: Clinical Trials

1 trial sponsored by Yangjin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1

Follow Yangjin: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Safety and Efficacy of SGLT2 Inhibitors in Pre-diabetic Patients
Dapagliflozin 10mg Tab, lifestyle interventions - Prediabetic State, Impaired Fasting Glucose
Phase 2UnknownYangjin1202023-12-202023-07-25

Conditions studied

Glucose Intolerance (1)  ·  Prediabetic State (1)

Interventions

dapagliflozin (1)

Countries

China (1)

Top investigators

Jin Yang, doctorate (1)

Results publications

PMID 38494571